Related Experiment Video
Updated: Jul 15, 2026
14:39
Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma
Published on: November 4, 2010
Early interventions in asthma with inhaled corticosteroids
L A Laitinen1, A Altraja, E M Karjalainen
1Department of Medicine, Helsinki University Central Hospital, Finland.
The Journal of Allergy and Clinical Immunology
|February 11, 2000
Summary
Asthma treatment guidelines recommend early anti-inflammatory drugs, but their effects on airway structural changes remain unclear. Further research is needed to determine if current asthma medication strategies adequately address airway remodeling.
Area of Science:
- Respiratory Medicine
- Cellular Biology
- Pharmacology
Background:
- Asthma is characterized by airway epithelial damage and subepithelial structural changes, including extracellular matrix deposition.
- Airway inflammation significantly influences these structural alterations in asthma patients.
- Current asthma management guidelines emphasize early anti-inflammatory drug use.
Purpose of the Study:
- To investigate the impact of asthma medications on the structural components of the airways.
- To assess whether current anti-inflammatory treatments are initiated early enough to prevent or reverse asthma-related airway remodeling.
Main Methods:
- Analysis of airway biopsy specimens from asthma patients.
- Evaluation of changes in extracellular matrix components and gene expression.
- Review of existing clinical studies on inhaled corticosteroid therapy.
Main Results:
- Inhaled corticosteroid therapy reduces airway inflammatory cell counts.
- Limited information exists regarding the effects of asthma medication on airway structural components.
- The influence of disease processes and drugs on extracellular matrix remodeling and gene expression requires further study.
Conclusions:
- While anti-inflammatory drugs reduce airway inflammation in asthma, their specific effects on airway structural remodeling are not well understood.
- The optimal timing for initiating anti-inflammatory treatment to manage asthma-related structural changes needs further investigation.
Related Concept Videos
01:25Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids
Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
01:25Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
01:26COPD: Management Using Bronchodilators and Corticosteroids
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
01:29Asthma-I: Introduction
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
01:30Asthma-IV: Diagnostic and Management
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
01:23Inhaled Medications
Inhaled medications are crucial for managing chronic obstructive pulmonary disease (COPD) and asthma. They are essential for effective treatment and control, ensuring optimal respiratory health and well-being. Inhaled medication delivers drugs directly to the lungs, providing a rapid onset of action and reducing systemic side effects compared to oral or injectable medications. Three primary types of inhalation devices are used to administer these medications: nebulizers, metered-dose inhalers...